Robbins LLP Informs Investors of Chemours Class Action Lawsuit
1 day ago
Robbins LLP announced a class action lawsuit against The Chemours Company, alleging overstated demand for Opteon products led to unreliable fiscal 2026 guidance. Following reduced EBITDA guidance, Chemours' stock price dropped significantly on August 5, 2026.
The National Law Review
Show all 119 updates